Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
M.D. Anderson Cancer Center
City of Hope Medical Center
Beijing GoBroad Hospital
Beijing GoBroad Hospital
Columbia University
Emory University
Peking Union Medical College Hospital
Columbia University
St. Olavs Hospital
Ludwig Institute for Cancer Research
Columbia University
Memorial Sloan Kettering Cancer Center
Northwestern University
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Northwestern University
Stanford University
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
University of Washington
University of Michigan
Samsung Medical Center
University of Minnesota
Asan Medical Center
M.D. Anderson Cancer Center
Northwestern University
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
McGill University
Boston University